MedPath

Comparative Evaluation Of Two Intranasal sleep inducing/calming Agents Among Children Undergoing Invasive Dental Procedures

Phase 4
Registration Number
CTRI/2024/07/069940
Lead Sponsor
Kashyap B
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Anxious paediatric patients aged 4–10 years with negative and definitely negative behavioural rating.

Belonging to American society of Anaesthesiologists (ASA) physical status I.

Whose treatment requires bilateral pulp therapy (pulpotomy/pulpectomy) in lower two quadrants under inferior alveolar nerve block. Whose treatment requires bilateral extraction in lower two quadrants under inferior alveolar nerve block

Children with no enlarged tonsils, no problem with neck movements and no oversized tongue.

Children with optimal SpO2 saturation.

Treatment modality only for first or second primary molars on both the sides

Exclusion Criteria

Children with cognitive impairment

Breathing difficulties,

History of systemic illness,

Hypersensitivity to midazolam/

Children with congenital heart disease.

Children on central nervous system (CNS) depressant drugs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath